Stay updated on Onasemnogene for SMA: Intrathecal Clinical Trial
Sign up to get notified when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.

Latest updates to the Onasemnogene for SMA: Intrathecal Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.5.2 replaces v3.5.0, indicating a minor software release.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check42 days agoChange Detected- Revision label updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page received a new site revision notice (Revision: v3.4.2) and an older notice (Revision: v3.4.1) was removed; these changes affect only site messaging and do not modify the study details, eligibility criteria, or data displayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check78 days agoChange DetectedAdded a government-funding site status notice and updated the page version to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check85 days agoChange DetectedThe page now includes a glossary feature and a plain-language trial summary link (novctrd.com), with the revision updated to v3.4.0 and the latest QC submission dated 2026-01-26. The older QC date (2023-04-24) and No FEAR Act data entries were removed.SummaryDifference0.4%

Stay in the know with updates to Onasemnogene for SMA: Intrathecal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.